- New commercial agreement with AstraZeneca
- US and EU patents for innovative CellKeepâ„¢ slide
- Parsortix HER2 assay showcased at AACR 2024
- Parsortix at European breast cancer conference
- Potential utility in precision oncology
- Standard form for notification of major holdings
- Breakthrough clinical results
- Contract announcement with Eisai Inc.
- Broker Announcement
- Parsortix unlocks opportunities for drug discovery
More ▼
Key statistics
On Thursday, Angle PLC (AGL:LSE) closed at 13.75, 51.65% above the 52 week low of 9.07 set on Nov 13, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 14.00 |
---|---|
High | 14.60 |
Low | 14.60 |
Bid | 13.50 |
Offer | 15.50 |
Previous close | 14.00 |
Average volume | 2.33m |
---|---|
Shares outstanding | 260.58m |
Free float | 232.60m |
P/E (TTM) | -- |
Market cap | 36.48m GBP |
EPS (TTM) | -0.086 GBP |
Data delayed at least 20 minutes, as of May 02 2024 15:56 BST.
More ▼